Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3701)
All Articles published online
|
Mar 21, 2005 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang GW, Yang LY, Lu WQ. Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. World J Gastroenterol 2005; 11(11): 1705-1708 [PMID: 15786555 DOI: 10.3748/wjg.v11.i11.1705] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i11/1705.htm |
| Number | Citing Articles |
| 1 |
Qi Zhang, Jiajun Wu, Xueli Bai, Tingbo Liang. Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.584250
|
| 2 |
Ni Zeng, Ye Wang, Yuan Wan, Hongyu Wang, Nan Li. The Antitumor Impact of Combining Hepatic Artery Ligation With Copper Chelators for Liver Cancer. Clinical Medicine Insights: Oncology 2023; 17 doi: 10.1177/11795549231204612
|
| 3 |
Ahmed O. Kaseb, Amr Hanbali, Matthew Cotant, Manal M. Hassan, Ira Wollner, Philip A. Philip. Vascular endothelial growth factor in the management of hepatocellular carcinoma. Cancer 2009; 115(21): 4895 doi: 10.1002/cncr.24537
|
| 4 |
Piotr Jan Wysocki. Targeted therapy of hepatocellular cancer. Expert Opinion on Investigational Drugs 2010; 19(2): 265 doi: 10.1517/13543780903514110
|
| 5 |
Ilias Mylonis, Achillia Lakka, Andreas Tsakalof, George Simos. The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions. Biochemical and Biophysical Research Communications 2010; 398(1): 74 doi: 10.1016/j.bbrc.2010.06.038
|
| 6 |
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn. Transcriptional regulators in hepatocarcinogenesis – Key integrators of malignant transformation. Journal of Hepatology 2012; 57(1): 186 doi: 10.1016/j.jhep.2011.11.029
|
| 7 |
Hiroki Tanaka, Masahiro Yamamoto, Norikazu Hashimoto, Masaaki Miyakoshi, Susumu Tamakawa, Masumi Yoshie, Yoshihiko Tokusashi, Kazunori Yokoyama, Yuji Yaginuma, Katsuhiro Ogawa. Hypoxia-Independent Overexpression of Hypoxia-Inducible Factor 1α as an Early Change in Mouse Hepatocarcinogenesis. Cancer Research 2006; 66(23): 11263 doi: 10.1158/0008-5472.CAN-06-1699
|
| 8 |
Shereen El Shorbagy, Fouad abuTaleb, Hany A. Labib, Huda Ebian, Ola A. Harb, Mona Saeed Mohammed, Hanaa A. Rashied, Khaled A. Elbana, Rasha Haggag. Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination. Journal of Gastrointestinal Cancer 2021; 52(1): 269 doi: 10.1007/s12029-020-00389-w
|
| 9 |
Eisuke Ueshima, Hideyuki Nishiofuku, Haruyuki Takaki, Yutaka Hirata, Hiroshi Kodama, Toshihiro Tanaka, Kimihiko Kichikawa, Koichiro Yamakado, Takuya Okada, Keitaro Sofue, Masato Yamaguchi, Koji Sugimoto, Takamichi Murakami. Hepatic Artery Embolization Induces the Local Overexpression of Transforming Growth Factor β1 in a Rat Hepatoma Model. Liver Cancer 2020; 9(1): 63 doi: 10.1159/000502774
|
| 10 |
|
| 11 |
Jing Fu, Yao Chen, Jie Cao, Tao Luo, You-Wen Qian, Wen Yang, Yi-Bin Ren, Bo Su, Guang-Wen Cao, Yuan Yang, Yi-Qun Yan, Feng Shen, Meng-Chao Wu, Gen-Sheng Feng, Hong-Yang Wang. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways. Hepatology 2011; 53(1): 181 doi: 10.1002/hep.24015
|
| 12 |
Sae Byeol Choi, Hyung Joon Han, Wan Bae Kim, Tae Jin Song, Sang Yong Choi. VEGF overexpression predicts poor survival in hepatocellular carcinoma. Open Medicine 2017; 12(1): 430 doi: 10.1515/med-2017-0061
|
| 13 |
Geng-Wen Huang, Yi-Ming Tao, Xiang Ding. Endocan Expression Correlated with Poor Survival in Human Hepatocellular Carcinoma. Digestive Diseases and Sciences 2009; 54(2): 389 doi: 10.1007/s10620-008-0346-3
|
| 14 |
Yinsong Wang, Hongli Chen, Yuanyuan Liu, Jing Wu, Ping Zhou, Yan Wang, Rongshan Li, Xiaoying Yang, Ning Zhang. pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma. Biomaterials 2013; 34(29): 7181 doi: 10.1016/j.biomaterials.2013.05.081
|
| 15 |
Femke Heindryckx, Pär Gerwins. Targeting the tumor stroma in hepatocellular carcinoma. World Journal of Hepatology 2015; 7(2): 165-176 doi: 10.4254/wjh.v7.i2.165
|
| 16 |
Y. Hu, H. E, X. Yu, F. Li, L. Zeng, Q. Lu, X. Xi, L. Shen. Correlation of quantitative parameters of magnetic resonance perfusion‐weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia‐inducible factor‐1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study. Clinical Otolaryngology 2018; 43(2): 425 doi: 10.1111/coa.12982
|
| 17 |
YAN SONG, LILI CAO. N-myc downstream-regulated gene 1: Diverse and complicated functions in human hepatocellular carcinoma (Review). Oncology Letters 2013; 6(6): 1539 doi: 10.3892/ol.2013.1636
|
| 18 |
Bal Krishan Sharma, Radhika Srinivasan, Shweta Kapil, Bhupesh Singla, Yogesh Kumar Chawla, Anuradha Chakraborti, Nitin Saini, Ajay Duseja, Ashim Das, Naveen Kalra, Radha Krishan Dhiman. Angiogenic and anti-angiogenic factor gene transcript level quantitation by quantitative real time PCR in patients with hepatocellular carcinoma. Molecular Biology Reports 2013; 40(10): 5843 doi: 10.1007/s11033-013-2690-4
|
| 19 |
Ronnie T. P. Poon, Cecilia Lau, Roberta Pang, Kelvin K. Ng, Jimmy Yuen, Sheung Tat Fan. High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies. Annals of Surgical Oncology 2007; 14(6): 1835 doi: 10.1245/s10434-007-9366-z
|
| 20 |
Antonio Diaz-Sanchez, Ana Matilla, Oscar Nuñez, Raquel Lorente, Alejandro Fernandez, Diego Rincón, Rocio Campos, Rafael Bañares, Gerardo Clemente. Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2013; 48(3): 334 doi: 10.3109/00365521.2012.746391
|
| 21 |
Maria Tampaki, Polyxeni P Doumba, Melanie Deutsch, John Koskinas. Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights. World Journal of Hepatology 2015; 7(14): 1834-1842 doi: 10.4254/wjh.v7.i14.1834
|
| 22 |
Jian Kong, Jinge Kong, Bing Pan, Shan Ke, Shuying Dong, Xiuli Li, Aimin Zhou, Lemin Zheng, Wen-bing Sun, Mercedes Susan Mandell. Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA. PLoS ONE 2012; 7(5): e37266 doi: 10.1371/journal.pone.0037266
|
| 23 |
Aki Pui-Wah Tse, Karen Man-Fong Sze, Queenie Tsung-Kwan Shea, Elley Yung-Tuen Chiu, Felice Ho-Ching Tsang, David Kung-Chun Chiu, Misty Shuo Zhang, Derek Lee, Iris Ming-Jing Xu, Cerise Yuen-Ki Chan, Hui-Yu Koh, Chun-Ming Wong, Yong-Ping Zheng, Irene Oi-Lin Ng, Carmen Chak-Lui Wong. Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. Oncogenesis 2018; 7(5) doi: 10.1038/s41389-018-0052-8
|
| 24 |
Daniela Valletta, Barbara Czech, Thilo Spruss, Kristian Ikenberg, Peter Wild, Arndt Hartmann, Thomas S. Weiss, Peter J. Oefner, Martina Müller, Anja-Katrin Bosserhoff, Claus Hellerbrand. Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma. Carcinogenesis 2014; 35(6): 1407 doi: 10.1093/carcin/bgu054
|
| 25 |
Feng Fang, Lai-Bang Luo, Yi-Ming Tao, Fan Wu, Lian-Yue Yang. Decreased Expression of Inhibitor of Growth 4 Correlated with Poor Prognosis of Hepatocellular Carcinoma. Cancer Epidemiology, Biomarkers & Prevention 2009; 18(2): 409 doi: 10.1158/1055-9965.EPI-08-0575
|
| 26 |
Elisa Pinto, Filippo Pelizzaro, Fabio Farinati, Francesco Paolo Russo. Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies. Medicina 2023; 59(6): 1115 doi: 10.3390/medicina59061115
|
| 27 |
Jian-hai Guo, Xu Zhu, Xiao-ting Li, Ren-jie Yang. Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Chinese Journal of Cancer Research 2012; 24(1): 36 doi: 10.1007/s11670-012-0036-8
|
| 28 |
Yoichiro Matsuo, Qiang Ding, Ryosuke Desaki, Kosei Maemura, Yuko Mataki, Hiroyuki Shinchi, Shoji Natsugoe, Sonshin Takao. Hypoxia inducible factor‐1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(2): 105 doi: 10.1002/jhbp.6
|
| 29 |
Chunping Wang, Yinying Lu, Yan Chen, Yongyi Feng, Linjing An, Xinzhen Wang, Shuhui Su, Wenlin Bai, Lin Zhou, Yongping Yang, Dongping Xu. Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study. Clinical & Experimental Metastasis 2009; 26(7): 839 doi: 10.1007/s10585-009-9283-6
|
| 30 |
Ahmed W. Moawad, Ali Morshid, Ahmed M. Khalaf, Mohab M. Elmohr, John D. Hazle, David Fuentes, Mohamed Badawy, Ahmed O. Kaseb, Manal Hassan, Armeen Mahvash, Janio Szklaruk, Aliyya Qayyum, Abdelrahman Abusaif, William C. Bennett, Tracy S. Nolan, Brittney Camp, Khaled M. Elsayes. Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation. Scientific Data 2023; 10(1) doi: 10.1038/s41597-023-01928-3
|
| 31 |
Takayuki Shimizu, Ken-ichi Inoue, Hiroyuki Hachiya, Norisuke Shibuya, Mitsugi Shimoda, Keiichi Kubota. Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas. Journal of Gastroenterology 2014; 49(9): 1324 doi: 10.1007/s00535-013-0895-x
|
| 32 |
Nurbubu T. Moldogazieva, Innokenty M. Mokhosoev, Alexander A. Terentiev. Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK. Cancers 2020; 12(4): 862 doi: 10.3390/cancers12040862
|
| 33 |
Ali Morshid, Khaled M. Elsayes, Ahmed M. Khalaf, Mohab M. Elmohr, Justin Yu, Ahmed O. Kaseb, Manal Hassan, Armeen Mahvash, Zhihui Wang, John D. Hazle, David Fuentes. A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization. Radiology: Artificial Intelligence 2019; 1(5): e180021 doi: 10.1148/ryai.2019180021
|
| 34 |
G. W. Huang, X. Ding, S. L. Chen, L. Zeng. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival. Journal of Cancer Research and Clinical Oncology 2011; 137(8): 1213 doi: 10.1007/s00432-011-0987-z
|
| 35 |
Elisa Pinto, Filippo Pelizzaro, Romilda Cardin, Michele Battistel, Giorgio Palano, Federica Bertellini, Maria Piera Kitenge, Giulia Peserico, Fabio Farinati, Francesco Paolo Russo. HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization. Digestive and Liver Disease 2024; 56(5): 872 doi: 10.1016/j.dld.2023.09.019
|
| 36 |
Lin Zhou, Jia Liu, Feng Luo. Serum tumor markers for detection of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(8): 1175-1181 doi: 10.3748/wjg.v12.i8.1175
|
| 37 |
Thomas K. Rhee, Joseph Y. Young, Andrew C. Larson, G. Kenneth Haines, Kent T. Sato, Riad Salem, Mary F. Mulcahy, Laura M. Kulik, Tatjana Paunesku, Gayle E. Woloschak, Reed A. Omary. Effect of Transcatheter Arterial Embolization on Levels of Hypoxia-inducible Factor-1α in Rabbit VX2 Liver Tumors. Journal of Vascular and Interventional Radiology 2007; 18(5): 639 doi: 10.1016/j.jvir.2007.02.031
|
| 38 |
Sonja Sibold, Vincent Roh, Adrian Keogh, Peter Studer, Céline Tiffon, Eliane Angst, Stephan A. Vorburger, Rosemarie Weimann, Daniel Candinas, Deborah Stroka. Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. FEBS Letters 2007; 581(5): 989 doi: 10.1016/j.febslet.2007.01.080
|
| 39 |
Takashi Himoto, Koji Fujita, Takako Nomura, Joji Tani, Hisaaki Miyoshi, Asahiro Morishita, Hirohito Yoneyama, Satoru Kubota, Reiji Haba, Yasuyuki Suzuki, Tsutomu Masaki. Roles of Copper in Hepatocarcinogenesis via the Activation of Hypoxia-Inducible Factor-1α. Biological Trace Element Research 2016; 174(1): 58 doi: 10.1007/s12011-016-0702-7
|
| 40 |
Ulrike Maegdefrau, Thomas Amann, Andreas Winklmeier, Simone Braig, Thomas Schubert, Thomas S Weiss, Katharina Schardt, Christina Warnecke, Claus Hellerbrand, Anja‐Katrin Bosserhoff. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. The Journal of Pathology 2009; 218(4): 520 doi: 10.1002/path.2563
|
| 41 |
Manuel Rodríguez-Perálvarez, Tu Vinh Luong, Lorenzo Andreana, Tim Meyer, Amar Paul Dhillon, Andrew Kenneth Burroughs. A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability. Annals of Surgical Oncology 2013; 20(1): 325 doi: 10.1245/s10434-012-2513-1
|
| 42 |
Carolina Méndez-Blanco, Paula Fernández-Palanca, Flavia Fondevila, Javier González-Gallego, José L. Mauriz. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis. Therapeutic Advances in Medical Oncology 2021; 13: 175883592098707 doi: 10.1177/1758835920987071
|
| 43 |
Hui Sheng, Minjie Mao, Kewei Huang, Hailin Zheng, Wen Liu, Yongneng Liang. A Clinical Tool to Predict the Microvascular Invasion Risk in Patients with Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231182526
|
| 44 |
Jennifer Wu, Merly Contratto, Krishna P Shanbhogue, Gulam A Manji, Bert H O’Neil, Anne Noonan, Robert Tudor, Ray Lee. Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma. World Journal of Clinical Oncology 2019; 10(3): 149-160 doi: 10.5306/wjco.v10.i3.149
|
| 45 |
Zi‐Niu Ding, Zhao‐Ru Dong, Zhi‐Qiang Chen, Ya‐Fei Yang, Lun‐Jie Yan, Hai‐Chao Li, Kai‐Xuan Liu, Cheng‐Yu Yao, Yu‐Chuan Yan, Chun‐Cheng Yang, Tao Li. Effects of hypoxia‐inducible factor‐1α and hypoxia‐inducible factor‐2α overexpression on hepatocellular carcinoma survival: A systematic review with meta‐analysis. Journal of Gastroenterology and Hepatology 2021; 36(6): 1487 doi: 10.1111/jgh.15395
|
| 46 |
Lauren E. Colbert, Sarah B. Fisher, Serdar Balci, Burcu Saka, Zhengjia Chen, Sungjin Kim, Bassel F. El-Rayes, N. Volkan Adsay, Shishir K. Maithel, Jerome C. Landry, Walter J. Curran. High Nuclear Hypoxia-Inducible Factor 1 Alpha Expression Is a Predictor of Distant Recurrence in Patients With Resected Pancreatic Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics 2015; 91(3): 631 doi: 10.1016/j.ijrobp.2014.11.004
|
| 47 |
Mai M. Abdelmageed, Reem N. El-Naga, Ebtehal El-Demerdash, Mohamed M. Elmazar. Indole-3- carbinol enhances sorafenib cytotoxicity in hepatocellular carcinoma cells: A mechanistic study. Scientific Reports 2016; 6(1) doi: 10.1038/srep32733
|
| 48 |
Jui-Chu Yang, Chiao-Fang Teng, Han-Chieh Wu, Hung-Wen Tsai, Huai-Chia Chuang, Ting-Fen Tsai, Yung-Hsiang Hsu, Wenya Huang, Li-Wha Wu, Ih-Jen Su. Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology 2009; 49(6): 1962 doi: 10.1002/hep.22889
|
| 49 |
Gregg L. Semenza. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discovery Today 2007; 12(19-20): 853 doi: 10.1016/j.drudis.2007.08.006
|
| 50 |
Lei Guo, Hong Fang, Jim Collins, Xiao-hui Fan, Stacey Dial, Alex Wong, Kshama Mehta, Ernice Blann, Leming Shi, Weida Tong, Yvonne P Dragan. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor α agonists. BMC Bioinformatics 2006; 7(S2) doi: 10.1186/1471-2105-7-S2-S18
|
| 51 |
Run AN, Jie MENG, Qi SHI, Xiao-Xia DAI, Jing-Hong CHEN, Yan-Jun LEI, Bing SHAN, Chen GAO, Yong-Lie CHU, Xiao-Ping DONG. Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma. Biomedical and Environmental Sciences 2010; 23(4): 267 doi: 10.1016/S0895-3988(10)60062-1
|
| 52 |
Yang‑Ling Li, Ming‑Jun Rao, Ning‑Yu Zhang, Lin‑Wen Wu, Neng‑Ming Lin, Chong Zhang. BAY 87‑2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK‑3β activation. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7500
|
| 53 |
Ana Campillo, Estela Solanas, Maria J. Morandeira, Tomas Castiella, Sara Lorente, Francisco Agustín Garcia-Gil, Elena Piazuelo, Alba de Martino, Maria T. Serrano. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation. European Journal of Gastroenterology & Hepatology 2014; 26(8): 871 doi: 10.1097/MEG.0000000000000131
|
| 54 |
Gui-Bo Wang, Xin-Yu Zhou, Xiao-Qin Wang. Relationship Between Serum Heparanase and Microscopic Venous Invasion in Patients With Hepatocellular Carcinoma. American Journal of Clinical Pathology 2010; 134(2): 242 doi: 10.1309/AJCPPJM6VHG4LPJX
|
| 55 |
Yang-ling Li, Ning-yu Zhang, Xiu Hu, Jia-ling Chen, Ming-jun Rao, Lin-wen Wu, Qing-yu Li, Bo Zhang, Wei Yan, Chong Zhang. Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia. Biochemical and Biophysical Research Communications 2018; 498(3): 481 doi: 10.1016/j.bbrc.2018.03.004
|
| 56 |
Zhen Song, Tengfei Liu, Jing Chen, Chao Ge, Fangyu Zhao, Miaoxin Zhu, Taoyang Chen, Ying Cui, Hua Tian, Ming Yao, Jinjun Li, Hong Li. HIF-1α-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib. Cancer Letters 2019; 460: 96 doi: 10.1016/j.canlet.2019.06.016
|
| 57 |
Asako Kimura, Kazuyuki Sogawa, Mamoru Satoh, Yoshio Kodera, Osamu Yokosuka, Takeshi Tomonaga, Fumio Nomura. The Application of a Three-Step Serum Proteome Analysis for the Discovery and Identification of Novel Biomarkers of Hepatocellular Carcinoma. International Journal of Proteomics 2012; 2012: 1 doi: 10.1155/2012/623190
|
| 58 |
Jacinth Wing-Sum Cheu, David Kung-Chun Chiu, Kenneth Kin-Leung Kwan, Chunxue Yang, Vincent Wai-Hin Yuen, Chi Ching Goh, Noreen Nog-Qin Chui, Wei Shen, Cheuk-Ting Law, Qidong Li, Misty Shuo Zhang, Macus Hao-Ran Bao, Bowie Po-Yee Wong, Cerise Yuen-Ki Chan, Cindy Xinqi Liu, Grace Fu-Wan Sit, Zher Yee Ooi, Haijing Deng, Aki Pui-Wah Tse, Irene Oi-Lin Ng, Carmen Chak-Lui Wong. Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development. Science Advances 2023; 9(18) doi: 10.1126/sciadv.ade5111
|
| 59 |
Yuji Morine, Mitsuo Shimada, Shuichi Iwahashi, Tohru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Hidenori Miyake. Role of histone deacetylase expression in intrahepatic cholangiocarcinoma. Surgery 2012; 151(3): 412 doi: 10.1016/j.surg.2011.07.038
|
| 60 |
Shiyi Cao, Shengli Yang, Chao Wu, Yunxia Wang, Jianxin Jiang, Zuxun Lu. Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: A systematic review with meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2014; 38(5): 598 doi: 10.1016/j.clinre.2014.04.004
|
| 61 |
Ruyue Ji, Chih-Ling Chou, Wei Xu, Xiao-Bo Chen, David F. Woodward, John W. Regan. EP1 Prostanoid Receptor Coupling to Gi/oUp-Regulates the Expression of Hypoxia-Inducible Factor-1α through Activation of a Phosphoinositide-3 Kinase Signaling Pathway. Molecular Pharmacology 2010; 77(6): 1025 doi: 10.1124/mol.110.063933
|
| 62 |
Yanqiong Liu, Jingzhe Sui, Limin Zhai, Shi Yang, Li Huang, Liying Huang, Cuiju Mo, Junrong Wu, Shan Li, Xue Qin. Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population. Medical Oncology 2014; 31(10) doi: 10.1007/s12032-014-0200-8
|
| 63 |
SEVGI BOZOVA, GÜLSÜM ÖZLEM ELPEK. Hypoxia‐inducible factor‐1α expression in experimental cirrhosis: correlation with vascular endothelial growth factor expression and angiogenesis. APMIS 2007; 115(7): 795 doi: 10.1111/j.1600-0463.2007.apm_610.x
|
| 64 |
Erdenebulgan Batmunkh, Mitsuo Shimada, Yuji Morine, Satoru Imura, Hirofumi Kanemura, Yusuke Arakawa, Jun Hanaoka, Mami Kanamoto, Koji Sugimoto, Masaaki Nishi. Expression of hypoxia-inducible factor-1 alpha (HIF-1α) in patients with the gallbladder carcinoma. International Journal of Clinical Oncology 2010; 15(1): 59 doi: 10.1007/s10147-009-0011-7
|
| 65 |
Audrey Lequeux, Muhammad Zaeem Noman, Malina Xiao, Delphine Sauvage, Kris Van Moer, Elodie Viry, Irene Bocci, Meriem Hasmim, Manon Bosseler, Guy Berchem, Bassam Janji. Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints. Cancer Letters 2019; 458: 13 doi: 10.1016/j.canlet.2019.05.021
|
| 66 |
Lei Wang, Jin-lin Peng. Association of hypoxia-inducible factor 1α expression with susceptibility to hepatitis B virus-related hepatocellular carcinoma: A meta-analysis. The International Journal of Biological Markers 2023; 38(3-4): 149 doi: 10.1177/03936155231204391
|
| 67 |
Femke Heindryckx, Stephanie Coulon, Ellen Terrie, Christophe Casteleyn, Jean-Marie Stassen, Anja Geerts, Louis Libbrecht, Joke Allemeersch, Peter Carmeliet, Isabelle Colle, Hans Van Vlierberghe. The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model. Journal of Hepatology 2013; 58(2): 319 doi: 10.1016/j.jhep.2012.09.032
|
| 68 |
Carmen Chak-Lui Wong, Alan Ka-Lun Kai, Irene Oi-Lin Ng. The impact of hypoxia in hepatocellular carcinoma metastasis. Frontiers of Medicine 2014; 8(1): 33 doi: 10.1007/s11684-013-0301-3
|
| 69 |
Danbi Lee, Myoung-Kuk Jang, Ji Hae Seo, Soo Hyung Ryu, Jeong A. Kim, Young-Hwa Chung. ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications. Experimental & Molecular Medicine 2018; 50(7): 1 doi: 10.1038/s12276-018-0106-1
|
| 70 |
Sumeet Virmani, Thomas K. Rhee, Robert K. Ryu, Kent T. Sato, Robert J. Lewandowski, Mary F. Mulcahy, Laura M. Kulik, Barbara Szolc-Kowalska, Gayle E. Woloschak, Guang-Yu Yang, Riad Salem, Andrew C. Larson, Reed A. Omary. Comparison of Hypoxia-inducible Factor-1α Expression before and after Transcatheter Arterial Embolization in Rabbit VX2 Liver Tumors. Journal of Vascular and Interventional Radiology 2008; 19(10): 1483 doi: 10.1016/j.jvir.2008.06.017
|
| 71 |
Thomas Amann, Ulrike Maegdefrau, Arndt Hartmann, Abbas Agaimy, Jörg Marienhagen, Thomas S. Weiss, Oliver Stoeltzing, Christina Warnecke, Jürgen Schölmerich, Peter J. Oefner, Marina Kreutz, Anja K. Bosserhoff, Claus Hellerbrand. GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis. The American Journal of Pathology 2009; 174(4): 1544 doi: 10.2353/ajpath.2009.080596
|
| 72 |
Ender G. Yegin, Aydos Siykhymbayev, Fatih Eren, Nural Bekiroglu, Osman Cavit Ozdogan. Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging. Annals of Hepatology 2013; 12(6): 915 doi: 10.1016/S1665-2681(19)31297-9
|
| 73 |
Jin Un Kim, Mohamed I F Shariff, Mary M E Crossey, Maria Gomez-Romero, Elaine Holmes, I Jane Cox, Haddy K S Fye, Ramou Njie, Simon D Taylor-Robinson. Hepatocellular carcinoma: Review of disease and tumor biomarkers. World Journal of Hepatology 2016; 8(10): 471-484 doi: 10.4254/wjh.v8.i10.471
|
| 74 |
Ivan Chebib, Meer Taher Shabani-Rad, Michelle S. Chow, James Zhang, Zu-hua Gao. Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma with and without Cirrhosis. Biomarker Insights 2007; 2: 117727190700200 doi: 10.1177/117727190700200013
|
| 75 |
Rashmi Nagesh, Rajeshwari H. Patil, M. Naveen Kumar, K.M. Kiran Kumar, Shivaleela Biradar, Babu R. Lamani. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 165 doi: 10.1016/B978-0-323-98807-0.00014-4
|
| 76 |
David J. Pinato, Mario Pirisi, Lynn Maslen, Rohini Sharma. Tissue Biomarkers of Prognostic Significance in Hepatocellular Carcinoma. Advances in Anatomic Pathology 2014; 21(4): 270 doi: 10.1097/PAP.0000000000000029
|
| 77 |
Fabio Grizzi, Barbara Franceschini, Cody Hamrick, Eldo E Frezza, Everardo Cobos, Maurizio Chiriva-Internati. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. Journal of Translational Medicine 2007; 5(1) doi: 10.1186/1479-5876-5-3
|
| 78 |
Lian-Yue Yang, Feng Fang, Di-Peng Ou, Wei Wu, Zhi-Jun Zeng, Fan Wu. Solitary Large Hepatocellular Carcinoma. Annals of Surgery 2009; 249(1): 118 doi: 10.1097/SLA.0b013e3181904988
|
| 79 |
Dong-Dong Guo, Kun-Feng Xie, Xing-Jing Luo. Hypoxia-induced elevated NDRG1 mediates apoptosis through reprograming mitochondrial fission in HCC. Gene 2020; 741: 144552 doi: 10.1016/j.gene.2020.144552
|
| 80 |
Seung Kak Shin, Sujin Ryu, Seungyoon Nam, Seung Yeon Ha, Oh Sang Kwon, Yun Soo Kim, Se-Hee Kim, Ju Hyun Kim. Clinical Significance of Combined Epithelial–Mesenchymal Transition Markers Expression and Role of Rac1 in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(2): 1765 doi: 10.3390/ijms24021765
|
| 81 |
Manojkumar Bupathi, Ahmed Kaseb, Funda Meric-Bernstam, Aung Naing. Hepatocellular carcinoma: Where there is unmet need. Molecular Oncology 2015; 9(8): 1501 doi: 10.1016/j.molonc.2015.06.005
|
| 82 |
Joonho Jeong, Jung Gu Park, Kwang Ill Seo, Ji Hyun Ahn, Jae Chun Park, Byung Cheol Yun, Sang Uk Lee, Jin Wook Lee, Jong Hyouk Yun. Microvascular invasion may be the determining factor in selecting TACE as the initial treatment in patients with hepatocellular carcinoma. Medicine 2021; 100(27): e26584 doi: 10.1097/MD.0000000000026584
|
| 83 |
Y-G Yoo, T-Y Na, H-W Seo, J K Seong, C K Park, Y K Shin, M-O Lee. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008; 27(24): 3405 doi: 10.1038/sj.onc.1211000
|
| 84 |
Ya-Ling Hsu, Po-Lin Kuo, Chien-Yu Cho, Wen-Chiu Ni, Tz-Fei Tzeng, Lean-Teik Ng, Yueh-Hsiung Kuo, Chun-Ching Lin. Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor κB pathway. Food and Chemical Toxicology 2007; 45(7): 1249 doi: 10.1016/j.fct.2007.01.005
|
| 85 |
Vincent Wai-Hin Yuen, Carmen Chak-Lui Wong. Hypoxia-inducible factors and innate immunity in liver cancer. Journal of Clinical Investigation 2020; 130(10): 5052 doi: 10.1172/JCI137553
|
| 86 |
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular Carcinoma. The Anatomical Record 2008; 291(6): 721 doi: 10.1002/ar.20668
|
| 87 |
S.-L. Yang, L.-P. Liu, J.-X. Jiang, Z.-F. Xiong, Q.-J. He, C. Wu. The Correlation of Expression Levels of HIF-1 and HIF-2 in Hepatocellular Carcinoma with Capsular Invasion, Portal Vein Tumor Thrombi and Patients' Clinical Outcome. Japanese Journal of Clinical Oncology 2014; 44(2): 159 doi: 10.1093/jjco/hyt194
|
| 88 |
Zhong-Lin Zhang, Zhi-Su Liu, Quan Sun. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(26): 4241-4245 doi: 10.3748/wjg.v12.i26.4241
|
| 89 |
Yufu Tang, Shupeng Liu, Nan Li, Weixing Guo, Jie Shi, Hongming Yu, Long Zhang, Kang Wang, Shangrong Liu, Shuqun Cheng. 14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α. Oncotarget 2016; 7(13): 15854 doi: 10.18632/oncotarget.7493
|
| 90 |
R Ji, CM Sanchez, CL Chou, XB Chen, DF Woodward, JW Regan. Prostanoid EP1 receptors mediate up‐regulation of the orphan nuclear receptor Nurr1 by cAMP‐independent activation of protein kinase A, CREB and NF‐κB. British Journal of Pharmacology 2012; 166(3): 1033 doi: 10.1111/j.1476-5381.2011.01817.x
|
| 91 |
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. European Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
|
| 92 |
Su-Su Zheng, Xiao-Hong Chen, Xin Yin, Bo-Heng Zhang, William B. Coleman. Prognostic Significance of HIF-1α Expression in Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE 2013; 8(6): e65753 doi: 10.1371/journal.pone.0065753
|
| 93 |
Melanie Thomas. Molecular targeted therapy for hepatocellular carcinoma. Journal of Gastroenterology 2009; 44(S19): 136 doi: 10.1007/s00535-008-2252-z
|
| 94 |
Pei‐Ching Hsiao, Mu‐Kuan Chen, Shih‐Chi Su, Kwo‐Chang Ueng, Yi‐Chen Chen, Yi‐Hsien Hsieh, Yu‐Fan Liu, Hsiu‐Ting Tsai, Shun‐Fa Yang. Hypoxia inducible factor‐1α gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. Journal of Surgical Oncology 2010; 102(2): 163 doi: 10.1002/jso.21539
|
| 95 |
Chung Doan, Long Le, Son Hoang, Si Do, Dong Le. Simultaneous silencing of VEGF and KSP by siRNA cocktail inhibits proliferation and induces apoptosis of hepatocellular carcinoma Hep3B cells. Biological Research 2014; 47(1): 70 doi: 10.1186/0717-6287-47-70
|
| 96 |
A.M. Khalaf, D. Fuentes, A. Morshid, A.O. Kaseb, M. Hassan, J.D. Hazle, K.M. Elsayes. Hepatocellular carcinoma response to transcatheter arterial chemoembolisation using automatically generated pre-therapeutic tumour volumes by a random forest-based segmentation protocol. Clinical Radiology 2019; 74(12): 974.e13 doi: 10.1016/j.crad.2019.07.023
|
| 97 |
Heng Xiao, Rongliang Tong, Shaobing Cheng, Zhen Lv, Chaofeng Ding, Chengli Du, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng. BAG3 and HIF-1αCoexpression Detected by Immunohistochemistry Correlated with Prognosis in Hepatocellular Carcinoma after Liver Transplantation. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/516518
|
| 98 |
Stefania Cannito, Umberto Dianzani, Maurizio Parola, Emanuele Albano, Salvatore Sutti. Inflammatory processes involved in NASH-related hepatocellular carcinoma. Bioscience Reports 2023; 43(1) doi: 10.1042/BSR20221271
|
| 99 |
Hoang Van Tong, Pham Van Dung, Nguyen Thi Mong Diep, Nguyen Linh Toan. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.98483
|
| 100 |
Meicheng Chen, Xiaoqi Zhou, Huasong Cai, Di Li, Chenyu Song, Huayu You, Ruixia Ma, Zhi Dong, Zhenpeng Peng, Shi‐Ting Feng. Evaluation of Hypoxia in Hepatocellular Carcinoma Using Quantitative MRI: Significances, Challenges, and Advances. Journal of Magnetic Resonance Imaging 2023; 58(1): 12 doi: 10.1002/jmri.28694
|
| 101 |
Weiguang Xu, Jung-Hee Kwon, Young Ho Moon, Young Bae Kim, Yun Suk Yu, Namgyu Lee, Kwan Yong Choi, Yun Soo Kim, Yong Keun Park, Bong Wan Kim, Hee Jung Wang. Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2014; 140(9): 1507 doi: 10.1007/s00432-014-1713-4
|
| 102 |
Asmaa I Gomaa, Shahid A Khan, Edward LS Leen, Imam Waked, Simon D Taylor-Robinson. Diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2009; 15(11): 1301-1314 doi: 10.3748/wjg.15.1301
|
| 103 |
Frank Simon, Maximilian Bockhorn, Christian Praha, Hideo A. Baba, Christoph E. Broelsch, Andrea Frilling, Frank Weber. Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue—influence of a modulated host stroma on the prognosis of HCC. Langenbeck's Archives of Surgery 2010; 395(4): 395 doi: 10.1007/s00423-009-0590-9
|
| 104 |
Jung Hwa Lim, Dae-Ghon Kim, Dae-Yeul Yu, Hyun Mi Kang, Kyung Hee Noh, Dae-Soo Kim, Dongmin Park, Tae Kyung Chang, Dong-Soo Im, Cho-Rok Jung. Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression. Cellular and Molecular Life Sciences 2019; 76(13): 2647 doi: 10.1007/s00018-019-03066-9
|
| 105 |
|
| 106 |
Sylene C.R. Carvalho, Luydson R.S. Vasconcelos, Leonardo da Fonseca, Rodrigo F. Carmo, Michele T. Tomitão, Dayse C.B.L. Aroucha, Leila M.M.B. Pereira, José Tadeu Stefano, Ulysses Ribeiro-Júnior, Claudia P. Oliveira, Flair J. Carrilho. Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). Clinics 2021; 76: e2881 doi: 10.6061/clinics/2021/e2881
|
| 107 |
Xinrui Yan, Mei-Sze Chua, Hongbo Sun, Samuel So. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Letters 2008; 262(1): 133 doi: 10.1016/j.canlet.2007.12.010
|
| 108 |
YAN-YAN SONG, LI-DAN SUN, MIN-LI LIU, ZHONG-LIANG LIU, FEI CHEN, YING-ZHE ZHANG, YAN ZHENG, JIAN-PING ZHANG. STAT3, p-STAT3 and HIF-1α are associated with vasculogenic mimicry and impact on survival in gastric adenocarcinoma. Oncology Letters 2014; 8(1): 431 doi: 10.3892/ol.2014.2059
|
| 109 |
Carmen Oi-ning Leung, Carmen Chak-lui Wong, Dorothy Ngo-yin Fan, Alan Ka-lun Kai, Edmund Kwok-kwan Tung, Iris Ming-jing Xu, Irene Oi-lin Ng, Regina Cheuk-lam Lo. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma. Oncotarget 2015; 6(13): 10880 doi: 10.18632/oncotarget.3534
|
| 110 |
Bal Krishan Sharma, Radhika Srinivasan, Shweta Kapil, Bhupesh Singla, Nitin Saini, Yogesh Kumar Chawla, Anuradha Chakraborti, Ajay Duseja, Naveen Kalra, Radha Krishan Dhiman. Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma. Molecular and Cellular Biochemistry 2013; 383(1-2): 103 doi: 10.1007/s11010-013-1759-7
|
| 111 |
Femke Heindryckx, Eliene Bogaerts, Stephanie H. Coulon, Hilde Devlies, Anja M. Geerts, Louis Libbrecht, Jean Marie Stassen, Peter Carmeliet, Isabelle O. Colle, Hans R. Van Vlierberghe. Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model. European Journal of Gastroenterology & Hepatology 2012; 24(9): 1020 doi: 10.1097/MEG.0b013e3283554219
|
| 112 |
Jun Muto, Ken Shirabe, Keishi Sugimachi, Yoshihiko Maehara. Review of angiogenesis in hepatocellular carcinoma. Hepatology Research 2015; 45(1): 1 doi: 10.1111/hepr.12310
|
| 113 |
Zhong-zhi Jia, Guo-min Jiang, Yao-liang Feng. Serum HIF-1α and VEGF Levels Pre- and Post-TACE in Patients with Primary Liver Cancer. Chinese Medical Sciences Journal 2011; 26(3): 158 doi: 10.1016/S1001-9294(11)60041-2
|
| 114 |
Amedeo Sciarra, Maxime Ronot, Luca Di Tommaso, Carlotta Raschioni, Laurent Castera, Jacques Belghiti, Pierre Bedossa, Valérie Vilgrain, Massimo Roncalli, Valérie Paradis. TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma. Liver International 2015; 35(11): 2466 doi: 10.1111/liv.12844
|
| 115 |
Qiu-Ping Liu, Xun Xu, Fei-Peng Zhu, Yu-Dong Zhang, Xi-Sheng Liu. Prediction of prognostic risk factors in hepatocellular carcinoma with transarterial chemoembolization using multi-modal multi-task deep learning. EClinicalMedicine 2020; 23: 100379 doi: 10.1016/j.eclinm.2020.100379
|
| 116 |
Etay Ziv, Yiru Zhang, Luke Kelly, Ines Nikolovski, F. Edward Boas, Joseph P. Erinjeri, Liqun Cai, Elena N. Petre, Lynn A. Brody, Anne M. Covey, George Getrajdman, James J. Harding, Constantinos Sofocleous, Ghassan K. Abou-Alfa, Stephen B. Solomon, Karen T. Brown, Hooman Yarmohammadi. NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation. Radiology 2020; 297(1): 225 doi: 10.1148/radiol.2020200201
|